Deloitte B Pharma & M Pharma Medical Writer Vacancy – Apply Online
At Deloitte’s USI S&A team, we are looking for Consultants / Senior Consultants, with relevant experience in regulatory affairs, medical writing for new molecular entity submission dossiers.
The Strategy and Analytics Offering Portfolio helps clients achieve breakthrough value by developing integrated strategies to win in their chosen markets and by architecting data-driven programs that transform their business.
Job Title: Medical Writer
Job Location: Bangalore, Gurgaon
Office Timings: 11 AM to 8 PM
Eligibility Criteria:Â
- PhD/MD/MS/M. Pharma/B. Pharma from a premier school in India or abroad is preferred.
- Qualifications in medical writing such as AMWA,EMWA, RAC desired
- Minimum 2+ years of relevant experience
- Hands-on exposure working in the Life Sciences (Pharmaceutical / Biotech), CROs, or health authorities (e.g., FDA, EMA etc.) is desired
- Understanding and experience in Oncology would be a plus
Required Experience
- Experience in medical writing or regulatory affairs
- Experience working on submission dossiers in clinical, Chemistry, Manufacturing & Control (CMC), labeling or pre-clinical domains
- Experience working with health authorities (knowledge of global, regional, national, and other document development guidelines)
- Experience working in the pharmaceutical/CRO industry
- Understanding of Regulatory Information Management systems as a plus
- Demonstrated experience in writing or contributing to scientific publications as a plus.
- Excellent written, verbal, and presentation skills along with top-tier communication and listening skills
- Strong grammatical, editorial, and proof-reading skills
Exceptional interpersonal, team-building and communication skills (both internally and with clients) - Tolerance for working in ambiguous, uncertain, autonomous environments
Commitment to personal and professional growth
Strategy: Therapeutic Area Transformation
The healthcare and life sciences industry has long been viewed as the place where innovation is commercialized: research and development pipelines produce products with increasing therapeutic benefits that then fuel the exponential growth of pharmaceutical and biotechnology companies across the world and change broader healthcare.
But the environment has changed and manufacturers can no longer play successfully across all therapeutic areas due to:
- Less efficient and less productive pipelines
- Expiry of blockbuster products and growing competition
- New care models resulting in a shift in decision-makers and centers of influence
- Reduced access to customers and changing modes of and types of interactions
- Evolving science and comparative effectiveness
- Healthcare and life science companies must constantly stay on top of the needs of the marketplace to avoid pitfalls or else miss important opportunities. As a result, manufacturers are being forced to rationalize and rebalance their portfolios to better compete.
- Yesterday’s approach of owning and commercializing a promising product in a new therapeutic area with limited experience and no future pipeline strategy is no longer a safe bet. The LSHC industry is full of cautionary tales from manufacturers that thought having positive clinical data and an unmet medical need were enough to succeed and providers have experienced this not to happen while payors are wary of high drug costs.
Deloitte’s Therapeutic Area Transformation Practice provides a unified market, pursuit or offering for clients or pursuits that need a TA based focus (e.g., diabetes, oncology, immunology, neurology) to be effective in improving cost, quality, access, and value to patients
Work you will do: Deloitte’s ‘Strategy’ service line helps companies address the entire range of top management challenges including pursuing new growth opportunities, developing go-to-market strategies, channel strategies, and pricing strategies.
· Develop client deliverables and documentation:
- Develop standardized content for submission dossiers, along with data-standards
- Analyze and interpret project data, draw conclusions and develop recommendations based on the result of the specific outputs
- Strive to improve deliverable quality through QC verification and validation of outputs
- Act as the Subject Matter Advisor (SMA) for relevant projects
- Conduct KOL/Client/SME interviews, participate in workshops and training sessions, and present recommendations
- Assist in developing proposals and collateral
Editors Note: Deloitte B Pharma Subscribe to Rasayanika for the latest chemistry and Pharma job openings, follow us on Facebook and Telegram and subscribe to our youtube channel for the latest updates on chemistry and Pharma jobs and much more.
